Department of Biology, York University, Toronto, Ontario, Canada.
Stellate Therapeutics, New York, New York, United States of America.
PLoS Genet. 2021 Sep 29;17(9):e1009828. doi: 10.1371/journal.pgen.1009828. eCollection 2021 Sep.
Transcription-related proteins are frequently identified as targets of sumoylation, including multiple subunits of the RNA polymerase II (RNAPII) general transcription factors (GTFs). However, it is not known how sumoylation affects GTFs or whether they are sumoylated when they assemble at promoters to facilitate RNAPII recruitment and transcription initiation. To explore how sumoylation can regulate transcription genome-wide, we performed SUMO ChIP-seq in yeast and found, in agreement with others, that most chromatin-associated sumoylated proteins are detected at genes encoding tRNAs and ribosomal proteins (RPGs). However, we also detected 147 robust SUMO peaks at promoters of non-ribosomal protein-coding genes (non-RPGs), indicating that sumoylation also regulates this gene class. Importantly, SUMO peaks at non-RPGs align specifically with binding sites of GTFs, but not other promoter-associated proteins, indicating that it is GTFs specifically that are sumoylated there. Predominantly, non-RPGs with SUMO peaks are among the most highly transcribed, have high levels of TFIIF, and show reduced RNAPII levels when cellular sumoylation is impaired, linking sumoylation with elevated transcription. However, detection of promoter-associated SUMO by ChIP might be limited to sites with high levels of substrate GTFs, and promoter-associated sumoylation at non-RPGs may actually be far more widespread than we detected. Among GTFs, we found that TFIIF is a major target of sumoylation, specifically at lysines 60/61 of its Tfg1 subunit, and elevating Tfg1 sumoylation resulted in decreased interaction of TFIIF with RNAPII. Interestingly, both reducing promoter-associated sumoylation, in a sumoylation-deficient Tfg1-K60/61R mutant strain, and elevating promoter-associated SUMO levels, by constitutively tethering SUMO to Tfg1, resulted in reduced RNAPII occupancy at non-RPGs. This implies that dynamic GTF sumoylation at non-RPG promoters, not simply the presence or absence of SUMO, is important for maintaining elevated transcription. Together, our findings reveal a novel mechanism of regulating the basal transcription machinery through sumoylation of promoter-bound GTFs.
转录相关蛋白通常被鉴定为 SUMO 化的靶标,包括 RNA 聚合酶 II(RNAPII)通用转录因子(GTF)的多个亚基。然而,尚不清楚 SUMO 化如何影响 GTF,或者它们在组装到启动子上以促进 RNAPII 募集和转录起始时是否被 SUMO 化。为了探索 SUMO 化如何在全基因组范围内调节转录,我们在酵母中进行了 SUMO ChIP-seq,结果与其他人的结果一致,即在编码 tRNA 和核糖体蛋白(RPG)的基因上检测到大多数与染色质相关的 SUMO 化蛋白。然而,我们还在非核糖体蛋白编码基因(非-RPG)的启动子上检测到 147 个强 SUMO 峰,表明 SUMO 化也调节了这一类基因。重要的是,非-RPG 上的 SUMO 峰特异性地与 GTF 的结合位点对齐,而不是与其他启动子相关蛋白对齐,表明那里特异性地被 SUMO 化的是 GTF。主要的是,具有 SUMO 峰的非-RPG 属于转录水平最高的基因之列,TFIIF 水平较高,当细胞 SUMO 化受损时,RNAPII 水平降低,将 SUMO 化与转录水平升高联系起来。然而,通过 ChIP 检测到的启动子相关 SUMO 可能仅限于具有高底物 GTF 水平的位点,并且非-RPG 上的启动子相关 SUMO 化实际上可能比我们检测到的更为广泛。在 GTF 中,我们发现 TFIIF 是 SUMO 化的主要靶标,特别是在其 Tfg1 亚基的赖氨酸 60/61 上,提高 Tfg1 SUMO 化导致 TFIIF 与 RNAPII 的相互作用减少。有趣的是,在 SUMO 化缺陷的 Tfg1-K60/61R 突变菌株中降低启动子相关 SUMO 化,以及通过将 SUMO 持续固定在 Tfg1 上提高启动子相关 SUMO 水平,都会导致非-RPG 上的 RNAPII 占有率降低。这意味着非-RPG 启动子上的 GTF 动态 SUMO 化,而不仅仅是 SUMO 的存在或不存在,对于维持转录水平升高很重要。总之,我们的发现揭示了一种通过 SUMO 化结合在启动子上的 GTF 来调节基本转录机制的新机制。